drugset / Trial / NCT02486211

Amantadine to Speed Awakening After Cardiac Arrest

NCT02486211

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates if amantadine will increase the rate of awakening in patients resuscitated from cardiac arrest but comatose (not following commands) after their resuscitation. Half of the participants will receive amantadine and the other will receive placebo.

Timeline

Start
2015-09
Primary completion
2018-06-30
Completion
2018-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Amantadine Unknown 100 mg Oral

Indications